 |
|
Photodynamic Therapy With Verteporfin using Half Fluence for Chronic Central Serous Chorioretinopathy.
Mun Hee Chang, Seong Woo Kim, Jae Ryung Oh, Kuhl Huh
J Korean Ophthalmol Soc. 2009;50(9):1326-1333. Published online 2009 Sep 15 DOI: https://doi.org/10.3341/jkos.2009.50.9.1326
|
|
Citations to this article as recorded by
 Factors Influencing the Effect of the Intravitreal Bevacizumab Injection in Patients with Central Serous Chorioretinopathy
Eui Yong Kweon
Journal of the Korean Ophthalmological Society.2014; 55(3): 391. CrossRef Comparison of Therapeutic Effect Between Half-Energy Photodynamic Therapy and Intravitreal Bevacizumab Injection in Chronic Central Serous Chorioretinopathy for 12 Months
Young Seung Kim, Young Hoon Lee, Hyoung Seok Kim, Sun Young Jin, Tae Gon Lee
Journal of the Korean Ophthalmological Society.2013; 54(10): 1526. CrossRef Comparison of Very Low Fluence and Low Fluence Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
Hyun Ju Oh, Woohyok Chang, Min Sagong
Journal of the Korean Ophthalmological Society.2013; 54(7): 1046. CrossRef Correlation Between Optical Coherence Tomography and Visual-Acuity in Chronic Central Serous Chorioretinopathy Treated with Half Dose Photodynamic Therapy
Si Yoon Park, Hyung Jun Koh, Yong Min Kim
Journal of the Korean Ophthalmological Society.2013; 54(11): 1715. CrossRef Photodynamic Therapy for Chronic Central Serous Chorioretinopathy According to Degree of Choroidal Hyperfluorescence
Su-Ho Lim, Woo Hyok Chang, Min Sagong
Journal of the Korean Ophthalmological Society.2012; 53(2): 268. CrossRef
|